Şunu aradınız:: vildagliptin (Maltaca - İngilizce)

vildagliptin
vildagliptin

vildagliptin/ metformin hydrochloride
vildagliptin/metformin hydrochloride

studju 2384: vildagliptin 50 mg
study 2384: vildagliptin 50 mg

galvus 50 mg pilloli vildagliptin
galvus 50 mg tablets vildagliptin

is-sustanza attiva hi vildagliptin.
the active substance is vildagliptin.

kull pillola fiha 50 mg ta’ vildagliptin.
each tablet contains 50 mg of vildagliptin.

vildagliptin ma jistax jitneħħa b’emodijalisi.
vildagliptin cannot be removed by haemodialysis.

mhumiex rakkomandati dożi ogħla minn 100 mg vildagliptin.
doses of vildagliptin above 100 mg are not recommended.

vildagliptin 50 mg darbtejn kuljum (n=79)
vildagliptin 50 mg twice daily (n=79)

informazzjoni dwar doża eċċessiva b’ vildagliptin hija limitata.
information regarding overdose with vildagliptin is limited.

50 mg vildagliptin u 1, 000 mg metformina kloridrat).
50 mg vildagliptin and 1,000 mg metformin hydrochloride).

dożi ogħla minn 100 mg ta ’ vildagliptin mhumiex rakkomandati.
doses higher than 100 mg of vildagliptin are not recommended.

xiliarx huwa mediċina li fiha s- sustanza attiva vildagliptin.
xiliarx is a medicine containing the active substance vildagliptin.

ma kienx hemm studji fejn metformin ġie miżjud ma’ vildagliptin.
there have been no studies of metformin added to vildagliptin.

studji fl-annimali wrew li vildagliptin jitneħħa fil-ħalib.
animal studies have shown excretion of vildagliptin in milk.

studju 2301: vildagliptin 50 mg darbtejn kuljum (n=90)
study 2301: vildagliptin 50 mg twice daily (n=90)

vildagliptin jintuża għall- kura ta ’ dijabete mellitus tat- tip 2:
vildagliptin is indicated in the treatment of type 2 diabetes mellitus:

l- inibizzjoni ta’ dpp-4 minn vildagliptin mhiex effettwata mis-sess.
dpp-4 inhibition by vildagliptin is not affected by gender.

icandra 50 mg/1000 mg pilloli miksijin b’rita vildagliptin/metformin hydrochloride
icandra 50 mg/1000 mg film-coated tablets vildagliptin/metformin hydrochloride

ma kienx hemm każijiet ta’ ipogliċemija severa rrappurtati fil-friegħi ta’ vildagliptin.
no severe hypoglycaemic events were reported in the vildagliptin arms.